Home | About PR | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |   Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
This article has been cited by
1Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
Vânia Meireles,Tiago Rosado,Mário Barroso,Sofia Soares,Joana Gonçalves,Ângelo Luís,Débora Caramelo,Ana Simão,Nicolás Fernández,Ana Duarte,Eugenia Gallardo
Medicines.2019;6(1)35
[DOI]
2Cerebellum and endocannabinoid receptors: a new neurobiological link for mitragynine (Mitragyna speciosa Korth) abuse liability
Christian Müller
Journal of Addiction and Dependence.2015;1(1)1
[DOI]
3Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal
Lisa L. Wilson,Soumen Chakraborty,Shainnel O. Eans,Thomas J. Cirino,Heather M. Stacy,Chloe A. Simons,Rajendra Uprety,Susruta Majumdar,Jay P. McLaughlin
Cellular and Molecular Neurobiology.2021;1(1)1
[DOI]
4Methanolic extract of Mitragyna speciosa Korth leaf inhibits ethanol seeking behaviour in mice: involvement of antidopaminergic mechanism
Kamini Vijeepallam,Vijayapandi Pandy,Dharmani Devi Murugan,Murali Naidu
Metabolic Brain Disease.2019;34(6)1713
[DOI]
5Pharmacokinetics and pharmacodynamics of mitragynine, the principle alkaloid of Mitragyna speciosa: present knowledge and future directions in perspective of pain
Dinesh Sangarran Ramachandram,Thenmoly Damodaran,Hadzliana Zainal,Vikneswaran Murugaiyah,Surash Ramanathan
Journal of Basic and Clinical Physiology and Pharmacology.2020;31(1)1713
[DOI]
6Dose-Response Relationship, Acute Toxicity, and Therapeutic Index between the Alkaloid Extract ofMitragyna speciosaand Its Main Active Compound Mitragynine in Mice
Azadeh Sabetghadam,Visweswaran Navaratnam,Sharif Mahsufi Mansor
Drug Development Research.2013;74(1)23
[DOI]
7Experiences of Kratom Users: A Qualitative Analysis
Marc T. Swogger,Elaine Hart,Fire Erowid,Earth Erowid,Nicole Trabold,Kaila Yee,Kimberly A. Parkhurst,Brittany M. Priddy,Zach Walsh
Journal of Psychoactive Drugs.2015;47(5)360
[DOI]
8Understanding the Physicochemical Properties of Mitragynine, a Principal Alkaloid of Mitragyna speciosa, for Preclinical Evaluation
Surash Ramanathan,Suhanya Parthasarathy,Vikneswaran Murugaiyah,Enrico Magosso,Soo Tan,Sharif Mansor
Molecules.2015;20(3)4915
[DOI]
9Neurobiology of Kratom and its main alkaloid mitragynine
Farah W. Suhaimi,Nurul H.M. Yusoff,Rahimah Hassan,Sharif M. Mansor,Visweswaran Navaratnam,Christian P. Müller,Zurina Hassan
Brain Research Bulletin.2016;126(3)29
[DOI]
10Mitragyna speciosa Leaf Extract Exhibits Antipsychotic-Like Effect with the Potential to Alleviate Positive and Negative Symptoms of Psychosis in Mice
Kamini Vijeepallam,Vijayapandi Pandy,Thubasni Kunasegaran,Dharmani D. Murugan,Murali Naidu
Frontiers in Pharmacology.2016;7(3)29
[DOI]
11Acute mitragynine administration suppresses cortical oscillatory power and systems theta coherence in rats
Rachel-Karson Thériault,Joshua D Manduca,Colin R Blight,Jibran Y Khokhar,Tariq A Akhtar,Melissa L Perreault
Journal of Psychopharmacology.2020;34(7)759
[DOI]
12The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse
Andrew C. Kruegel,Oliver Grundmann
Neuropharmacology.2018;134(7)108
[DOI]
13Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic
Albert Garcia-Romeu,David J. Cox,Kirsten E. Smith,Kelly E. Dunn,Roland R. Griffiths
Drug and Alcohol Dependence.2020;208(7)107849
[DOI]
14Kratom (Mitragyna speciosa): worldwide issues
Surash Ramanathan,Christopher R. McCurdy
Current Opinion in Psychiatry.2020;33(4)312
[DOI]
15Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats
Azadeh Sabetghadam,Surash Ramanathan,Sreenivasan Sasidharan,Sharif Mahsufi Mansor
Journal of Ethnopharmacology.2013;146(3)815
[DOI]
16Discriminative stimulus properties of mitragynine (kratom) in rats
Norsyifa Harun,Zurina Hassan,Visweswaran Navaratnam,Sharif M. Mansor,Mohammed Shoaib
Psychopharmacology.2015;232(13)2227
[DOI]
17From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction
Zurina Hassan,Mustapha Muzaimi,Visweswaran Navaratnam,Nurul H.M. Yusoff,Farah W. Suhaimi,Rajakumar Vadivelu,Balasingam K. Vicknasingam,Davide Amato,Stephan von Hörsten,Nurul I.W. Ismail,Nanthini Jayabalan,Ammar I. Hazim,Sharif M. Mansor,Christian P. Müller
Neuroscience & Biobehavioral Reviews.2013;37(2)138
[DOI]
18Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
Zurina Hassan,Oliver G. Bosch,Darshan Singh,Suresh Narayanan,B. Vicknasingam Kasinather,Erich Seifritz,Johannes Kornhuber,Boris B. Quednow,Christian P. Müller
Frontiers in Psychiatry.2017;8(2)138
[DOI]
19Endogenous opiates and behavior: 2010
Richard J. Bodnar
Peptides.2011;32(12)2522
[DOI]
  Feedback 
  Subscribe